These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8056690)

  • 1. Loss of bactericidal activities of quinolones during the post-antibiotic effect induced by rifampicin.
    Meng X; Nightingale CH; Sweeney KR; Quintiliani R
    J Antimicrob Chemother; 1994 Apr; 33(4):721-8. PubMed ID: 8056690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postantibiotic effect of ciprofloxacin compared with that of five other quinolones.
    Minguez F; Ramos C; Barrientos S; Loscos A; Prieto J
    Chemotherapy; 1991; 37(6):420-5. PubMed ID: 1760941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Quinolone bactericidal mechanisms.
    Howard BM; Pinney RJ; Smith JT
    Arzneimittelforschung; 1993 Oct; 43(10):1125-9. PubMed ID: 7505585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the in vivo post-antibiotic effects of ciprofloxacin and rifampicin.
    Meng X; Pei Y; Nightingale CH; Quintiliani R
    J Antimicrob Chemother; 1995 Dec; 36(6):987-96. PubMed ID: 8821597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-antibiotic effect induced by an antibiotic combination: influence of mode, sequence and interval of exposure.
    Li RC; Tang MC
    J Antimicrob Chemother; 2004 Nov; 54(5):904-8. PubMed ID: 15375112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-antibiotic effect of three quinolones against gram negative isolates from urine.
    Alados JC; Gutierrez J; Garcia F; Liebana J; Piedrola G
    Med Lab Sci; 1990 Oct; 47(4):272-7. PubMed ID: 2283929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms.
    Howard BM; Pinney RJ; Smith JT
    Microbios; 1994; 77(311):121-31. PubMed ID: 8152392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postantibiotic effect of CI-960, enoxacin and ciprofloxacin on Escherichia coli: effect on morphology and haemolysin activity.
    Guan L; Burnham JC
    J Antimicrob Chemother; 1992 May; 29(5):529-38. PubMed ID: 1320604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of order of magnesium exposure on the postantibiotic effect and bactericidal activity of ciprofloxacin.
    Li RC; Lo KN; Lam JS; Lau PY
    J Chemother; 1999 Aug; 11(4):243-7. PubMed ID: 10465124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antimicrobial interactions of arthemeter with some 4-quinolones.
    Esimone CO; Adikwu MU; Nwafor SV; Okoli CO; Ndu OO; Nwoke OI
    Boll Chim Farm; 2002; 141(5):385-8. PubMed ID: 12481382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Susceptibility to norfloxacin of some bacterial strains causing urinary infections].
    Tuchiluş C; Poiată A; Bădicuţ I; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):383-6. PubMed ID: 16607805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of 4-quinolones against Pseudomonas aeruginosa.
    Morissey I; Smith JT
    Arzneimittelforschung; 1994 Oct; 44(10):1157-61. PubMed ID: 7818593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditions required for the bactericidal activity of fleroxacin and pefloxacin against Escherichia coli KL 16.
    Lewin CS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):83-6. PubMed ID: 1693968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of the 4-quinolones with other antibacterials.
    Lewin CS; Smith JT
    J Med Microbiol; 1989 Jul; 29(3):221-7. PubMed ID: 2664184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of Smith's quinolone killing mechanisms during the PAE of ciprofloxacin on Escherichia coli.
    Wickens HJ; Pinney RJ
    Int J Pharm; 2001 Oct; 227(1-2):149-56. PubMed ID: 11564549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of macromolecular biosynthesis to define the quinolone-induced postantibiotic effect in Escherichia coli.
    Guan L; Blumenthal RM; Burnham JC
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2118-24. PubMed ID: 1280055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant prevention concentration of nalidixic acid, ciprofloxacin, clinafloxacin, levofloxacin, norfloxacin, ofloxacin, sparfloxacin or trovafloxacin for Escherichia coli under different growth conditions.
    Linde HJ; Lehn N
    J Antimicrob Chemother; 2004 Feb; 53(2):252-7. PubMed ID: 14688048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model.
    Zinner SH; Vostrov SN; Alferova IV; Lubenko IY; Portnoy YA; Firsov AA
    Int J Antimicrob Agents; 2004 Aug; 24(2):173-7. PubMed ID: 15288317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity of a 1,8-naphthyridine quinolone, PD 131628.
    Lewin CS
    J Med Microbiol; 1992 May; 36(5):353-7. PubMed ID: 1316970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.